Saudi Central Bank Has $32.46 Million Stock Position in Cigna Group $CI

Saudi Central Bank lifted its position in shares of Cigna Group (NYSE:CIFree Report) by 8.0% in the second quarter, HoldingsChannel reports. The fund owned 115,702 shares of the health services provider’s stock after buying an additional 8,596 shares during the period. Saudi Central Bank’s holdings in Cigna Group were worth $32,458,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Brighton Jones LLC boosted its stake in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Sivia Capital Partners LLC raised its stake in shares of Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after buying an additional 109 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina boosted its stake in Cigna Group by 16.6% in the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after acquiring an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in Cigna Group during the 2nd quarter worth $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 1.4%

Shares of NYSE CI opened at $282.24 on Friday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The stock has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a P/E/G ratio of 0.97 and a beta of 0.31. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The company’s fifty day moving average is $283.51 and its 200-day moving average is $281.07.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts predict that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 23,012 shares of company stock valued at $6,386,550 over the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on CI. Sanford C. Bernstein upped their target price on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 29th. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Piper Sandler decreased their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Finally, Morgan Stanley upped their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average target price of $339.45.

Check Out Our Latest Research Report on CI

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.